SLXN 8-K: Delisting notice
Filed with the SEC on · accession 0001178913-26-005294
SLXN filed a 8-K (current report) with the SEC on Nov 19, 2026. Silexion Therapeutics received a favorable Nasdaq Hearings Panel decision granting continued listing on the Nasdaq Capital Market, subject to conditions including completing a $2.5 million private placement by December 4, 2026, demonstrating a $1.00 minimum bid price by November 24, 2026, and…
Summary of the filing
Silexion Therapeutics received a favorable Nasdaq Hearings Panel decision granting continued listing on the Nasdaq Capital Market, subject to conditions including completing a $2.5 million private placement by December 4, 2026, demonstrating a $1.00 minimum bid price by November 24, 2026, and completing a public offering of at least $5 million by March 31, 2027. The company had previously effected a 1-for-24 reverse share split on November 10, 2026 to address the bid price deficiency.
Key details
✦ Ask GOAX AI about this filing — what it means for SLXN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SLXN?
Click hereFrequently asked questions
What did SLXN file with the SEC on Nov 19, 2026?
SLXN filed a 8-K (Delisting notice). Silexion Therapeutics received a favorable Nasdaq Hearings Panel decision granting continued listing on the Nasdaq Capital Market, subject to conditions including completing a $2.5 million private placement by December 4, 2026, demonstrating a $1.00 minimum bid price by November 24, 2026, and completing a public offering of at least $5 million by March 31, 2027. The company had previously effected a 1-for-24 reverse share split on November 10, 2026 to address the bid price deficiency.
What does a delisting notice mean for SLXN stock?
The stock often falls sharply. In a Chapter 11 reorganization existing shares are frequently cancelled or heavily diluted; in Chapter 7 the company is liquidated and shareholders are paid last, usually nothing.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other SLXN SEC filings
- 8-K · SEC filingNov 16, 2026
- 8-K · Stock splitNov 12, 2026
- 10-Q · SEC filingNov 12, 2026
- 8-K · Stock splitNov 9, 2026
- EFFECT · Shelf registrationNov 9, 2026
- S-3 · Shelf registrationOct 28, 2026
- 8-K · SEC filingOct 26, 2026
- DEF 14A · Stock splitOct 5, 2026
- 8-K · Fda approvalSep 30, 2026
- 8-K · SEC filingSep 29, 2026
Get alerts when SLXN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days